Global Heparin Sodium Market Research Report 2017

Publisher Name :
Date: 10-Nov-2017
No. of pages: 141
Inquire Before Buying

With increasing downstream demand, global heparin sodium API production also increased from 90768 Kg in 2007 to 138099 Kg in 2012. In 2007, the global market of heparin sodium was valued at 222 million USD. From 2007 to 2012, as the price of heparin sodium increasing, global heparin sodium market has grown fivefold in market size. Over the past five years, the price of global heparin sodium has been declining. At present, the global heparin sodium market size is about 700 million USD. Global heparin sodium is mainly concentrated in China, Europe and United States. In 2012, China heparin sodium production share took about 64.74%. Production of Europe and United States separately took 15.42% and 18.76%. Global heparin sodium consumption areas are Europe, United States and China. In 2016, Europe consumed about 44.84% of global heparin sodium. United States consumed 21.94% and China consumed 29.86% of global heparin sodium. Most of China heparin sodium was exported to other countries.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The heparin sodium market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (China, Europe, USA, Row), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What's more, the heparin sodium industry development trends and marketing channels are analyzed.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Global Heparin Sodium Market Research Report 2017

Table of Contents
1 Heparin Sodium Market Overview 1
1.1 Product Overview and Scope of Heparin Sodium 1
1.2 Global Heparin Sodium Segment by Applications 1
1.2.1 Global Heparin Sodium Analysis by Applications 2
1.2.2 Treatment of Venous Thromboembolism 2
1.2.3 Complications of Pregnancy 2
1.2.4 Cardioversion of Atrial Fibrillation/Flutter 3
1.3 Heparin Sodium Market by Regions 3
1.3.1 USA Status and Prospect (2007-2018) 3
1.3.2 China Status and Prospect (2007-2018) 4
1.3.3 Europe Status and Prospect (2007-2018) 5
1.4 Global Market Size (Value) of Heparin Sodium (2007-2018) 6
2 Global Heparin Sodium Market Competition by Manufacturers 7
2.1 Global Heparin Sodium Capacity, Production and Share by Manufacturers (2007-2012) 7
2.2 Global Heparin Sodium Revenue and Share by Manufacturers (2007-2012) 13
2.3 Global Heparin Sodium Average Price by Manufacturers (2007-2012) 16
2.4 Manufacturers Heparin Sodium Manufacturing Base Distribution, Sales Area 18
2.5 Heparin Sodium Market Competitive Situation and Trends 19
2.5.1 Heparin Sodium Market Concentration Rate 19
2.5.2 Heparin Sodium Market Share of Top 3 and Top 5 Manufacturers 20
2.5.3 Industry News Analysis of Heparin Sodium 21
3 Global Heparin Sodium Capacity, Production, Revenue (Value) by Regions (2007-2012) 22
3.1 Global Heparin Sodium Capacity and Market Share by Regions (2007-2012) 22
3.2 Global Heparin Sodium Production and Market Share by Regions (2007-2012) 24
3.3 Global Heparin Sodium Revenue (Value) and Market Share by Regions (2007-2012) 26
3.4 Global Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 27
3.5 USA Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 28
3.6 Europe Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 28
3.7 China Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 29
4 Global Heparin Sodium Consumption (Kg) by Regions (2007-2012) 30
4.1 Global Heparin Sodium Consumption by Regions (2007-2012) 30
4.2 USA Heparin Sodium Consumption (Kg) (2012-2017) 32
4.3 Europe Heparin Sodium Consumption (Kg) (2012-2017) 33
4.4 China Heparin Sodium Consumption (Kg) (2012-2017) 34
4.5 Asia Other Heparin Sodium Consumption (Kg) (2012-2017) 35
5 Global Heparin Sodium Market Analysis by Applications 36
5.1 Global Heparin Sodium Consumption and Market Share by Applications (2007-2012) 36
5.2 Global Heparin Sodium Consumption Growth Rate by Applications (2007-2012) 37
5.3 Market Drivers and Opportunities 38
5.3.1 Potential Applications 38
5.3.2 Emerging Markets/Countries 38
6 Heparin Sodium Manufacturing Cost Analysis 39
6.1 Heparin Sodium Key Raw Materials Analysis 39
6.1.1 Fresh Intestine 39
6.1.2 Pancreatic Enzymes 39
6.1.3 Ion Exchange Resin 40
6.1.4 Preservative 42
6.2 Proportion of Manufacturing Cost Structure 43
6.2.1 Raw Materials 43
6.2.2 Labor Cost 44
6.2.3 Manufacturing Expenses 49
6.3 Manufacturing Process Analysis of Heparin Sodium 49
7 Global Heparin Sodium Manufacturers Profiles/Analysis 51
7.1 Shenzhen Hepalink 51
7.1.1 Company Profile 51
7.1.2 Heparin Sodium Product Information 52
7.1.3 Shenzhen Hepalink Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 52
7.1.4 Contact Information 53
7.2 Nanjing King-friend 54
7.2.1 Company Profile 54
7.2.2 Heparin Sodium Product Information 55
7.2.3 Nanjing King-friend Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 56
7.2.4 Contact Information 57
7.3 Dongcheng Biochemicals 57
7.3.1 Company Profile 57
7.3.2 Heparin Sodium Product Information 58
7.3.3 Dongcheng Biochemicals Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 59
7.3.4 Contact Information 60
7.4 Changzhou Qianhong Bio-pharma 60
7.4.1 Company Profile 60
7.4.2 Heparin Sodium Product Information 61
7.4.3 Changzhou Qianhong Bio-pharma Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 62
7.4.4 Contact Information 63
7.5 Changshan Biochemical 63
7.5.1 Company Profile 63
7.5.2 Heparin Sodium Product Information 64
7.5.3 Changshan Biochemical Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 65
7.5.4 Contact Information 66
7.6 Dongying Tiandong Pharmaceutical 66
7.6.1 Company Profile 66
7.6.2 Heparin Sodium Product Information 67
7.6.3 Dongying Tiandong Pharmaceutical Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 68
7.6.4 Contact Information 69
7.7 Xinbai Pharmaceuticals 69
7.7.1 Company Profile 69
7.7.2 Heparin Sodium Product Information 70
7.7.3 Xinbai Pharmaceuticals Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 70
7.7.4 Contact Information 71
7.8 SPL 71
7.8.1 Company Profile 71
7.8.2 Heparin Sodium Product Information 72
7.8.3 SPL Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 73
7.8.4 Contact Information 73
7.9 Bioibérica 74
7.9.1 Company Profile 74
7.9.2 Heparin Sodium Product Information 74
7.9.3 Bioibérica Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 75
7.9.4 Contact Information 76
7.10 Baxter 76
7.10.1 Company Profile 76
7.10.2 Heparin Sodium Product Information 77
7.10.3 Baxter Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 77
7.10.4 Contact Information 78
7.11 Opocrin 78
7.11.1 Company Profile 78
7.11.2 Heparin Sodium Product Information 79
7.11.3 Opocrin Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 79
7.11.4 Contact Information 80
7.12 Aspen Oss 80
7.12.1 Company Profile 80
7.12.2 Heparin Sodium Product Information 81
7.12.3 Aspen Oss Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 82
7.13.4 Contact Information 82
7.13 Pharma Action 83
7.13.1 Company Profile 83
7.13.2 Heparin Sodium Product Information 83
7.13.3 Pharma Action Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 84
7.13.4 Contact Information 85
7.14 Pfizer 85
7.14.1 Company Profile 85
7.14.2 Heparin Sodium Product Information 86
7.14.3 Pfizer Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 87
7.14.4 Contact Information 87
8 Industrial Chain, Sourcing Strategy and Downstream Buyers 89
8.1 Heparin Sodium Industrial Chain Analysis 89
8.2 Upstream Raw Materials Sourcing 89
8.3 Raw Materials Sources of Heparin Sodium Major Manufacturers in 2016 90
8.4 Downstream Buyers 91
9 Marketing Strategy Analysis, Distributors/Traders 94
9.1 Marketing Channel 94
9.1.1 Direct Marketing 94
9.1.2 Indirect Marketing 96
9.1.3 Marketing Channel Development Trend 97
9.2 Market Positioning 98
9.2.1 Pricing Strategy 98
9.2.2 Brand Strategy 100
9.2.3 Target Client 101
9.3 Distributors/Traders List 101
10 Market Effect Factors Analysis 103
10.1 Technology Progress/Risk 103
10.1.1 Substitutes Threat 103
10.1.2 Technology Progress in Related Industry 103
10.2 Consumer Needs/Customer Preference Change 103
10.3 Economic/Political Environmental Change 104
11 Global Heparin Sodium Market (2013-2018) 105
11.1 Global Heparin Sodium Capacity, Production, Revenue (2013-2018) 105
11.1.1 Global Heparin Sodium Capacity, Production (Kg) and Growth Rate (%) (2013-2018) 105
11.1.2 Global Heparin Sodium Revenue (Million USD) and Growth Rate (%) (2013-2018) 106
11.1.3 Global Heparin Sodium Price and Trend (2013-2018) 107
11.2 Global Heparin Sodium Production (Kg) by Regions (2013-2018) 107
11.2.1 USA Heparin Sodium Production (Kg) and Revenue (Million USD) (2013-2018) 109
11.2.2 Europe Heparin Sodium Production (Kg), Revenue (Million USD) (2013-2018) 111
11.2.3 China Heparin Sodium Production (Kg), Revenue (Million USD) (2013-2018) 113
11.3 Global Heparin Sodium Consumption (Kg) by Regions (2013-2018) 114
11.3.1 USA Heparin Sodium Consumption (Kg) (2013-2018) 116
11.3.2 Europe Heparin Sodium Consumption (Kg) (2013-2018) 117
11.3.3 China Heparin Sodium Consumption (Kg) (2013-2018) 118
11.3.4 Asia Other Heparin Sodium Consumption (Kg) (2013-2018) 119
11.4 Global Heparin Sodium Consumption by Application (2013-2018) 119
12 Research Findings and Conclusion 121
13 Appendix 123
Disclosure Section 123
Research Methodology 123
Data Source 125
Disclaimer 125
Author List 127
List of Tables and Figures
Figure Product Picture of Heparin Sodium 1
Table Applications of Heparin Sodium 1
Figure Global Heparin Sodium Consumption (Sales) Market Share by Applications in 2012 2
Figure USA Heparin Sodium Revenue (Million USD) and Growth Rate (2007-2018) 3
Figure China Heparin Sodium Revenue (Million USD) and Growth Rate (2007-2018) 4
Figure Europe Heparin Sodium Revenue (Million USD) and Growth Rate (2007-2018) 5
Figure Global Heparin Sodium Revenue (Million USD) and Growth Rate (2007-2018) 6
Table Global Heparin Sodium Capacity (Kg) of Key Manufacturers (2007-2012) 7
Table Global Heparin Sodium Capacity Market Share of Key Manufacturers (2007-2012) 7
Figure Global Heparin Sodium Capacity of Key Manufacturers in 2011 9
Figure Global Heparin Sodium Capacity of Key Manufacturers in 2012 10
Table Global Heparin Sodium Production (Kg) of Key Manufacturers (2007-2012) 10
Table Global Heparin Sodium Production Share by Manufacturers (2007-2012) 11
Figure 2011 Heparin Sodium Production Share by Manufacturers 12
Figure 2012 Heparin Sodium Production Share by Manufacturers 13
Table Global Heparin Sodium Revenue (Million USD) by Manufacturers (2007-2012) 13
Table Global Heparin Sodium Revenue Share by Manufacturers (2007-2012) 14
Figure 2011 Global Heparin Sodium Revenue Share by Manufacturers 15
Figure 2012 Global Heparin Sodium Revenue Share by Manufacturers 16
Table Global Market Heparin Sodium Average Price (USD/Kg) of Key Manufacturers (2007-2012) 16
Figure Global Market Heparin Sodium Average Price (USD/Kg) of Key Manufacturers in 2012 18
Table Manufacturers Heparin Sodium Manufacturing Base Distribution and Sales Area 18
Figure Heparin Sodium Top 3 and Top 5 Production Market Share (2007-2012) 19
Figure Heparin Sodium Market Share of Top 3 Manufacturers in 2012 20
Figure Heparin Sodium Market Share of Top 5 Manufacturers in 2012 20
Table Industry News List of Heparin Sodium 21
Table Global Heparin Sodium Capacity (Kg) by Regions (2007-2012) 22
Table Global Heparin Sodium Capacity Market Share by Regions (2007-2012) 22
Figure Global Heparin Sodium Capacity Market Share by Regions (2007-2012) 23
Figure 2012 Global Heparin Sodium Capacity Market Share by Regions 23
Table Global Heparin Sodium Production (Kg) by Regions (2007-2012) 24
Table Global Heparin Sodium Production and Market Share by Regions (2007-2012) 24
Figure Global Heparin Sodium Production Market Share by Regions (2007-2012) 25
Figure 2012 Global Heparin Sodium Production Market Share by Regions 25
Table Global Heparin Sodium Revenue (Million USD) by Regions (2007-2012) 26
Table Global Heparin Sodium Revenue Market Share by Regions (2007-2012) 26
Figure 2012 Global Heparin Sodium Revenue Market Share by Regions 27
Table Global Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 27
Table USA Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 28
Table Europe Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 28
Table China Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 29
Table Global Heparin Sodium Consumption (Kg) Market by Regions (2007-2012) 30
Table Global Heparin Sodium Consumption Market Share by Regions (2007-2012) 30
Figure Global Heparin Sodium Consumption Market Share by Regions (2007-2012) 31
Figure 2012 Global Heparin Sodium Consumption Market Share by Regions 31
Figure USA Heparin Sodium Consumption and Growth Rate (%) (2012-2017) 32
Figure Europe Heparin Sodium Consumption and Growth Rate (%) (2012-2017) 33
Figure China Heparin Sodium Consumption and Growth Rate (%) (2012-2017) 34
Figure Asia Other Heparin Sodium Consumption and Growth Rate (%) (2012-2017) 35
Table Global Heparin Sodium Consumption (Kg) by Applications (2007-2012) 36
Table Global Heparin Sodium Consumption Market Share by Applications (2007-2012) 36
Figure Global Heparin Sodium Consumption Market Share by Applications in 2012 37
Table Global Heparin Sodium Consumption Growth Rate by Applications (2007-2012) 37
Figure Global Heparin Sodium Consumption Growth Rate by Applications (2007-2012) 38
Figure Picture of Fresh Intestine 39
Figure Picture of Pancreatic Enzymes 40
Figure Ion-exchange Resin Product Picture 40
Figure 2010-2015 Global Ion-exchange Resin Capacity (K MT), Production (K MT) and Growth Rate 41
Figure 2010-2015 Global Ion-exchange Resin Price (USD/MT) 41
Table Raw Material Suppliers and Contact Information 42
Figure Manufacturing Cost Structure of Heparin Sodium in 2016 43
Figure USA Labor Cost Analysis 44
Figure Cost of Employing a Factory Worker 46
Figure 2015 Estimated Labor Costs for the Whole Economy in EUR 47
Figure Monthly Minimum Wages in Asia 2016 48
Figure China Labor Costs 48
Figure Manufacturing Process Analysis of Heparin Sodium by Salt Solution Method 49
Figure Manufacturing Process Analysis of Heparin Sodium by Enzyme Extraction Method 50
Table Shenzhen Hepalink Profile 51
Figure Heparin Sodium Picture of Shenzhen Hepalink 52
Table Shenzhen Hepalink Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 52
Figure Shenzhen Hepalink Heparin Sodium Production Market Share (2007-2012) 53
Table Nanjing King-friend Profile 54
Figure Heparin Sodium Picture of Nanjing King-friend 55
Table Heparin Sodium Specifications of Nanjing King-friend 55
Table Nanjing King-friend Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 56
Figure Nanjing King-friend Heparin Sodium Production Market Share (2007-2012) 57
Table Dongcheng Biochemicals Profile 57
Figure Heparin Sodium Picture of Dongcheng Biochemicals 58
Table Heparin Sodium Specifications of Dongcheng Biochemicals 58
Table Dongcheng Biochemicals Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 59
Figure Dongcheng Biochemicals Heparin Sodium Production Market Share (2007-2012) 59
Table Changzhou Qianhong Bio-pharma Profile 60
Figure Heparin Sodium Picture of Changzhou Qianhong Bio-pharma 61
Table Heparin Sodium Specifications of Changzhou Qianhong Bio-pharma 61
Table Changzhou Qianhong Bio-pharma Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 62
Figure Changzhou Qianhong Bio-pharma Heparin Sodium Production Market Share (2007-2012) 62
Table Changshan Biochemical Profile 63
Figure Heparin Sodium Picture of Changshan Biochemical 64
Table Changshan Biochemical Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 65
Figure Changshan Biochemical Heparin Sodium Production Market Share (2007-2012) 66
Table Dongying Tiandong Pharmaceutical Profile 66
Figure Heparin Sodium Picture of Dongying Tiandong Pharmaceutical 67
Table Heparin Sodium Specifications of Dongying Tiandong Pharmaceutical 67
Table Dongying Tiandong Pharmaceutical Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 68
Figure Dongying Tiandong Pharmaceutical Heparin Sodium Production Market Share (2007-2012) 69
Table Xinbai Pharmaceuticals Profile 69
Figure Heparin Sodium Picture of Xinbai Pharmaceuticals 70
Table Xinbai Pharmaceuticals Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 70
Figure Xinbai Pharmaceuticals Heparin Sodium Production Market Share (2007-2012) 71
Table SPL Profile 71
Figure Heparin Sodium Picture of SPL 72
Table SPL Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 73
Figure SPL Heparin Sodium Production Market Share (2007-2012) 73
Table Bioibérica Profile 74
Table Heparin Sodium Product Information 74
Table Bioibérica Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 75
Figure Bioibérica Heparin Sodium Production Market Share (2007-2012) 76
Table Baxter Profile 76
Table Baxter Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 77
Figure Baxter Heparin Sodium Production Market Share (2007-2012) 78
Table Opocrin Profile 78
Table Heparin Sodium Product Information 79
Table Opocrin Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 79
Figure Opocrin Heparin Sodium Production Market Share (2007-2012) 80
Table Aspen Oss Profile 80
Table Aspen Oss Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 82
Figure Aspen Oss Heparin Sodium Production Market Share (2007-2012) 82
Table Pharma Action Profile 83
Table Heparin Sodium Product Information 83
Table Pharma Action Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 84
Figure Pharma Action Heparin Sodium Production Market Share (2007-2012) 85
Table Pfizer Profile 85
Figure Heparin Sodium Picture of Pfizer 86
Table Pfizer Heparin Sodium Capacity, Production, Revenue, Price and Gross Margin (2007-2012) 87
Figure Pfizer Heparin Sodium Production Market Share (2007-2012) 87
Figure Heparin Sodium Industrial Chain Analysis 89
Table Raw Materials Sources of Heparin Sodium Major Manufacturers in 2016 90
Table Major Buyers of Heparin Sodium 91
Table Distributors/Traders List 101
Figure Global Heparin Sodium Capacity, Production (Kg) and Growth Rate (%) (2013-2018) 105
Figure Global Heparin Sodium Revenue (Million USD) and Growth Rate (%) (2013-2018) 106
Figure Global Heparin Sodium Price (USD/Kg) and Trend (2013-2018) 107
Table Global Heparin Sodium Production (Kg) by Regions (2013-2018) 107
Figure Global Heparin Sodium Production Market Share (%) by Regions (2013-2018) 108
Figure USA Heparin Sodium Production (Kg) and Growth Rate (%) (2013-2018) 109
Figure USA Heparin Sodium Revenue (Million USD) and Growth Rate (%) (2013-2018) 110
Figure Europe Heparin Sodium Production (Kg) and Growth Rate (2013-2018) 111
Figure Europe Heparin Sodium Revenue (Million USD) and Growth Rate (%) (2013-2018) 112
Figure China Heparin Sodium Production (Kg) and Growth Rate (%) (2013-2018) 113
Figure China Heparin Sodium Revenue (Million USD) and Growth Rate (%) (2013-2018) 114
Table Global Heparin Sodium Consumption (Kg) by Regions (2013-2018) 114
Figure Global Heparin Sodium Consumption Market Share (%) by Regions (2013-2018) 115
Figure USA Heparin Sodium Consumption (Kg) and Growth Rate (%) (2013-2018) 116
Figure Europe Heparin Sodium Consumption (Kg) and Growth Rate (%) (2013-2018) 117
Figure China Heparin Sodium Consumption (Kg) and Growth Rate (%) (2013-2018) 118
Figure Asia Other Heparin Sodium Consumption (Kg) and Growth Rate (%) (2013-2018) 119
Table Global Heparin Sodium Consumption (Kg) by Application (2013-2018) 119
Figure Global Heparin Sodium Consumption by Application (2013-2018) 120
  • Global Low Molecular Weight Heparin Sales Market Report 2017
    Published: 17-Nov-2017        Price: US 4000 Onwards        Pages: 117
    In this report, the global Low Molecular Weight Heparin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Low Molecular Weight Heparin for these regions, from 2012 to 2022 (forecast), covering - United States - China - Eur......
  • China Fibrinogen Concentrate Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 17-Nov-2017        Price: US 4480 Onwards        Pages: 118
    Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Also known as "fibrin glue" or "fibrin sealant", the majority of available formulations contain a mixture of pooled plasma-derived fibrinogen and the enzyme thrombin. Scope of the Report: This report focuses on the Fibrinog......
  • Global Argatroban Sales Market Report 2017
    Published: 17-Nov-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the global Argatroban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Argatroban for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - Southeas......
  • Global and China Heparin Sodium Market Research by Company, Type & Application 2013-2025
    Published: 16-Nov-2017        Price: US 2000 Onwards        Pages: 105
    Summary Market Segment as follows: By Type - Type 1 - Type 2 - Type 3 By Application - Treatment of Venous Thromboembolism - Complications of Pregnancy - Cardioversion of Atrial Fibrillation/Flutter By Company - Shenzhen Hepalink - Bioibérica - Nanjing King-friend - Pfizer - SPL - Dongcheng Biochemicals - Changzhou Qianhong Bio-pharma - Cha......
  • Global Heparin Industry 2017 Market Research Report
    Published: 13-Nov-2017        Price: US 2900 Onwards        Pages: 147
    This report studies the Heparin market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Heparin market by product type and applications/end industries. In the last several years, Global market of Heparin developed rapidly, with an average growth rate of 3.3%. In 2016, Global Revenue of Heparin is nearly 910 M USD; the actual production ......
  • Global Low Molecular Weight Heparin Market Research Report 2017
    Published: 10-Nov-2017        Price: US 2900 Onwards        Pages: 107
    The global production of low molecular weight heparin increases from 12467 Kg in 2012 to 16852 Kg in 2016, at a CAGR of more than 7.82%. In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second's largest market with the share of 30.49%. This report studies Low Molecular Weight Heparin in Global market, especially in USA, Europe, China a......
  • Global Intravenous Immunoglobulin (IVIg) Market Research Report 2017
    Published: 09-Nov-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Intravenous Immunoglobulin (IVIg) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Intravenous Immunoglobulin (IVIg) in these regions, from 2012 to 2022 (forecast), covering - North America ......
  • Global and Regional Injectable Anticoagulants Market Research Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 122
    Summary The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South Ameri......
  • Global and Regional Anticoagulants Market Research Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 155
    Summary Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs